At Strategos BIP, through the #TrianglesStrategy, we work constantly to strengthen cooperation between authorities and productive sectors in the face of the growing challenges of illicit trade in Latin America.
A concrete result of this effort was seen recently in an operation carried out together with the pharmaceutical industry, which requested our intervention in a case of illicit storage and sale of medicines intended for the treatment of high-risk diseases such as diabetes and cardiovascular problems.

Thanks to the technical and strategic investigation carried out by Strategos BIP, key information was made available to SIJIN-GOES-MESOA and the Attorney General's Office, which made possible:
The capture and prosecution of the person responsible.
The seizure of more than 700 illegal medicines, many of them with alterations in manufacturing lots and expiration dates.
The protection of public health, by preventing these products from reaching the market and endangering consumers' lives.
The laboratories affected by this criminal practice included Genfar, Sanofi, Legrand Pharma, AstraZeneca, Asparta, Novarapid, Procats, Novaments, LaSanté Pharmaceutique and Roche Colombia.
This case demonstrates the real impact that illicit trade has on citizen security, public health and the competitiveness of the formal market. At Strategos BIP, we reaffirm our commitment to actively contributing to the prosecution of those responsible and to strengthening institutional capacities through information sharing and coordinated action.
Through our CIMA platform, we continue carrying out ongoing investigation, analysis and monitoring work to identify criminal patterns, support authorities in dismantling criminal networks and promote more effective public-private cooperation.
Learn more about this case here:
https://periodismopublico.com/alerta-en-soacha-capturan-a-hombre-por-venta-irregular-de-medicamentos

